Cargando…
Covid-19-vaccine-pfizer-biontech: Guillain-Barre syndrome: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417633/ http://dx.doi.org/10.1007/s40278-021-01653-2 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Guillain Barre Syndrome: case report
Publicado: (2021) -
Guillain-Barré Syndrome with Rapid Onset and Autonomic Dysfunction Following
First Dose of Pfizer-BioNTech COVID-19 Vaccine: A Case Report
por: Lanman, Tyler Ashford, et al.
Publicado: (2022) -
A case of Guillain–Barre syndrome following Pfizer COVID-19 vaccine
por: Rao, Shiavax J., et al.
Publicado: (2021) -
Guillain-Barré syndrome following the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases
por: Bouattour, Nadia, et al.
Publicado: (2021) -
Covid-19 vaccine-Pfizer-Biontech: Rhabdomyolysis: case report
Publicado: (2021)